- Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial
-
Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH
- KMID: 1785965
- J Korean Med Sci.
- 2011 Jun;26(6):785-790.
- doi: 10.3346/jkms.2011.26.6.785
The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Levofloxacin-based Triple Therapy as Second-lineHelicobacter pylori Eradication
-
Jung HS, Shim KN, Baik SJ, Na YJ, Kang MJ, Jung JM, Ha CY, Jung SA, Yoo K
- KMID: 1767528
- Korean J Gastroenterol.
- 2008 May;51(5):285-290.
BACKROUND/AIMS: Bismuth-based quadruple therapy for second-line eradication treatment achieves the eradication rate ranging from 70% to 81% due to antimicrobial resistance and poor compliance. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of Levofloxacin Based Triple Therapy for Helicobacter pylori Eradication
-
Lee JH, Hong SP, Kwon CI, Phyun LH, Lee BS, Song HU, Ko KH, Hwang SG, Park PW, Rim KS, Ki S
- KMID: 782733
- Korean J Gastroenterol.
- 2006 Jul;48(1):19-24.
BACKGROUND/AIMS: The failure rates of first and second line therapies of Helicobacter pylori (H. pylori) eradication range from 15 to 20%. This study was aimed to evaluate the efficacy and... -
- CITED
-
- Close
- SHARE
-
- Close
- Levofloxacin-Azithromycin Combined Triple Therapy for Helicobacter pylori Eradication
-
Kang MS, Park DI, Yun JW, Oh SY, Yoo TW, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI
- KMID: 1079901
- Korean J Gastroenterol.
- 2006 Jan;47(1):30-36.
BACKGROUND/AIMS: Antibiotic resistance and poor compliance are the main causes of Helicobacter pylori (H. pylori) eradication failure. This study evaluated the eradication rate, tolerability, and compliance of levofloxacin-... -
- CITED
-
- Close
- SHARE
-
- Close
